Tag: KDIGO 2025

IgA Nephropathy: Prognosis and Current Therapies in 2026

IgA Nephropathy is the most common cause of primary kidney inflammation worldwide. New 2025 guidelines recommend combining targeted therapies like Nefecon with blood pressure control to slow progression. Learn the latest prognosis, treatment options, and real-world challenges.